, /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: ) (the "Company") is pleased to announce that it has engaged , CPA, CA as Business Advisor. Ms.
Davison is a Chartered Professional Accountant and owner of Davison CPA Consulting Inc., of . She previously served as Chief Accounting Officer and Acting Chief Financial Officer at IMV Inc.
, where she led a Public Offering in and assisted in raising more than during her ten-year tenure at IMV Inc. Ms. Davison was instrumental in IMV Inc.
gaining a Nasdaq listing in 2018, and was involved in transactional business development, partnering and investor relations activities. Prior to IMV, she was an Audit Senior with Grant Thornton LLP. , BioVaxys President & Chief Operating Officer, stated, "We are delighted to have engaged Brittany who is a significant addition to our team where she will assist with further knowledge transfer associated with the former IMV, Inc.
assets, support investor relations, business development targeting and outreach, and facilitate sources of private funding, government funding and Scientific Research and Experimental Development (SR&ED) tax incentives." BioVaxys Technology Corp. ( ) registered in , is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX® immune-educating technology platform and its HapTenix© "neoantigen" tumor cell construct platform, for treating cancers, infectious disease, antigen desensitiza.
